Literature DB >> 2138308

[2 cases of severe human babesiosis treated successfully].

A Gorenflot, P Brasseur, G Bonmarchand, D Laneele, D Simonin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2138308

Source DB:  PubMed          Journal:  Presse Med        ISSN： 0755-4982            Impact factor:   1.228


× No keyword cloud information.
  5 in total

1.  In vitro evaluation of drug susceptibilities of Babesia divergens isolates.

Authors:  P Brasseur; S Lecoublet; N Kapel; L Favennec; J J Ballet
Journal:  Antimicrob Agents Chemother       Date:  1998-04       Impact factor: 5.191

2.  Identification of major Babesia divergens polypeptides that induce protection against homologous challenge in gerbils.

Authors:  A Gorenflot; E Precigout; G Bissuel; O Lecointre; P Brasseur; E Vidor; M L'Hostis; J Schrevel
Journal:  Infect Immun       Date:  1990-12       Impact factor: 3.441

3.  Analysis of immune responses of different hosts to Babesia divergens isolates from different geographic areas and capacity of culture-derived exoantigens to induce efficient cross-protection.

Authors:  E Precigout; A Gorenflot; A Valentin; G Bissuel; B Carcy; P Brasseur; Y Moreau; J Schrevel
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

Review 4.  Babesiosis.

Authors:  M J Homer; I Aguilar-Delfin; S R Telford; P J Krause; D H Persing
Journal:  Clin Microbiol Rev       Date:  2000-07       Impact factor: 26.132

5.  Cytological and immunological responses to Babesia divergens in different hosts: ox, gerbil, man.

Authors:  A Gorenflot; P Brasseur; E Precigout; M L'Hostis; A Marchand; J Schrevel
Journal:  Parasitol Res       Date:  1991       Impact factor: 2.289
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.